Joakim Esbjörnsson

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. doi request reprint Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection
    Joakim Esbjörnsson
    Department of Experimental Medical Science, Section of Molecular Virology, Lund University, Lund, Sweden
    N Engl J Med 367:224-32. 2012
  2. pmc Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa
    Joakim Esbjörnsson
    Department of Experimental Medical Science, Section of Molecular Virology, Lund University, Lund, Sweden
    Retrovirology 7:23. 2010
  3. pmc HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations
    Joakim Esbjörnsson
    Section of Molecular Virology, Department of Experimental Medical Science, Lund University, Lund, Sweden
    PLoS ONE 6:e17025. 2011
  4. doi request reprint Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection
    Mattias Mild
    Department of Experimental Medical Science, Lund University, Sweden
    Infect Genet Evol 10:356-64. 2010
  5. ncbi request reprint Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load
    Ulf Karlsson
    Department of Clinical Sciences, Lund University, Lund, Sweden
    AIDS 26:1739-44. 2012
  6. ncbi request reprint Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency
    Johanna Repits
    Department of Laboratory Medicine, Division of Medical Microbiology, Lund University, Solvegatan 23, 223 62 Lund, Sweden
    J Gen Virol 86:2859-69. 2005
  7. pmc Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1
    Gülşen Ozkaya Sahin
    Department of Laboratory Medicine Lund, Lund University, Lund, Sweden
    J Virol 86:961-71. 2012
  8. pmc Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch
    Mattias Mild
    Department of Experimental Medical Science, Lund University, BMC B13, 221 84 Lund, Sweden
    J Virol 81:3369-76. 2007

Detail Information

Publications8

  1. doi request reprint Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection
    Joakim Esbjörnsson
    Department of Experimental Medical Science, Section of Molecular Virology, Lund University, Lund, Sweden
    N Engl J Med 367:224-32. 2012
    ....
  2. pmc Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa
    Joakim Esbjörnsson
    Department of Experimental Medical Science, Section of Molecular Virology, Lund University, Lund, Sweden
    Retrovirology 7:23. 2010
    ..We also performed a genotypic analysis and investigated subtype-specific differences in the appearance of CXCR4 tropism late in disease...
  3. pmc HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations
    Joakim Esbjörnsson
    Section of Molecular Virology, Department of Experimental Medical Science, Lund University, Lund, Sweden
    PLoS ONE 6:e17025. 2011
    ....
  4. doi request reprint Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection
    Mattias Mild
    Department of Experimental Medical Science, Lund University, Sweden
    Infect Genet Evol 10:356-64. 2010
    ..These molecular properties could prove important for understanding the evolution of coreceptor usage in HIV-1 populations, and maybe even for predicting an upcoming coreceptor switch at early stages after primary infection...
  5. ncbi request reprint Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load
    Ulf Karlsson
    Department of Clinical Sciences, Lund University, Lund, Sweden
    AIDS 26:1739-44. 2012
    ..To study the use of major and alternative coreceptors by HIV-1 isolates obtained from paired plasma and cerebrospinal fluid (CSF) samples...
  6. ncbi request reprint Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency
    Johanna Repits
    Department of Laboratory Medicine, Division of Medical Microbiology, Lund University, Solvegatan 23, 223 62 Lund, Sweden
    J Gen Virol 86:2859-69. 2005
    ..At a time when the clinical use of entry inhibitors is increasing, this observation could be of importance in the optimal design of such treatments...
  7. pmc Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1
    Gülşen Ozkaya Sahin
    Department of Laboratory Medicine Lund, Lund University, Lund, Sweden
    J Virol 86:961-71. 2012
    ..We suggest that immunogenicity and/or antigenicity, meaning the neutralization phenotype, of HIV-2 is distinct from that of HIV-1 and that HIV-2 may display structures that favor triggering of potent neutralizing antibody responses...
  8. pmc Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch
    Mattias Mild
    Department of Experimental Medical Science, Lund University, BMC B13, 221 84 Lund, Sweden
    J Virol 81:3369-76. 2007
    ..In conclusion, intrapatient recombination between viruses with distinct coreceptor usage may contribute to the emergence of X4 viruses in later stages of infection...